issue

Dec 2, 2022

Volume 18 Number 11

In this issue, an expert consensus document from the Society of Cardiovascular Computed Tomography on the use of cardiac computed tomography in the pre-procedural planning of PCIs. In coronary interventions: the EPIC STEMI trial looking at early initiation of alirocumab – a PCSK9 inhibitor – in treating STEMI patients undergoing PCI; the use of ticagrelor with and without aspirin in patients who will undergo PCI and who have had prior coronary artery bypass grafts from the TWILIGHT-CABG study; from the HOST REDUCE POLYTECH trial a look at the different stent polymers in DES and their impact on outcomes after a complex PCI; coronary collateral function after successful CTO PCI; worldwide CTO PCI – standardisation trends, outcomes and future developments; the design of the PROMISE trial looking at the best strategies for caring for MINOCA patients suffering from MI; in peripheral interventions: from the IN.PACT Global study, a look at the effectiveness of paclitaxel-coated balloons in treating PAD; and more...

Coronary interventions

Pre-procedural planning of coronary revascularization by cardiac computed tomography: An expert consensus document of the Society of Cardiovascular Computed Tomography
Andreini D, Collet C, Leipsic J, Nieman K, Bittencurt M, Mey Jd, Buls N, Onuma Y, Mushtaq S, Conte E, Bartorelli AL, Stefanini G, Sonck J, Knaapen P, Ghoshhajra B, Serruys PW
10.4244/EIJ-E-22-00036
free
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial
Mehta SR, Pare G, Lonn E, Jolly S, Natarajan MK, Pinilla-Echeverri N, Schwalm J, Sheth T, Sibbald M, Tsang M, Valettas N, Velianou J, Lee S, Ferdous T, Nauman S, Nguyen H, McCready T, McQueen M
10.4244/EIJ-D-22-00735
free
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
Sardella G, Beerkens F, Dangas G, Cao D, Baber U, Sartori S, Cohen D, Briguori C, Gil R, Nicolas J, Zhang Z, Dudek D, Kunadian V, Kornowski R, Weisz G, Claessen B, Marx S, Escaned J, Huber K, Collier T, Moliterno D, Ohman EM, Krucoff M, Kastrati A, Steg G, Angiolillo D, Mehta SR, Shlofmitz RA, Sharma S, Pocock S, Gibson C, Mehran R
10.4244/EIJ-D-22-00319
free

Editorial comment

Short DAPT for PCI after CABG: ready for prime time
Siller-Matula J, Sandner S
10.4244/EIJ-E-22-00048
free
Durable polymer versus biodegradable polymer drug-eluting stents in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: a post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial
Hwang D, Lim H, Park K, Shin W, Kang J, Han J, Yang H, Kang H, Koo B, Cho Y, Hong S, Kim S, Jo S, Kim Y, Kim W, Lee S, Oh S, Kim D, Kim H
10.4244/EIJ-D-22-00372
free
Changes in coronary collateral function after successful chronic total occlusion percutaneous coronary intervention
Keulards D, Alsanjari O, Keeble TR, Vlaar P, Kelly PA, Tang KH, Khan S, Cockburn J, Pijls N, Hildick-Smith D, Teeuwen K, Davies J, Karamasis GV
10.4244/EIJ-D-22-00118
free
In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion
Kostantinis S, Simsek B, Karacsonyi J, Alaswad K, Krestyaninov O, Khelimskii D, Karmpaliotis D, Jaffer F, Khatri J, Poommipanit P, Choi J, Jaber W, Rinfret S, Nicholson W, Patel M, Mahmud E, Dattilo P, Gorgulu S, Koutouzis M, Tsiafoutis I, Elbarouni B, Sheikh A, Uretsky B, ElGuindy A, Jefferson B, Patel T, Wollmuth J, Riley R, Benton S, Davies R, Chandwaney R, Toma C, Yeh R, Schimmel D, Abi-Rafeh N, Goktekin O, Kerrigan J, Mastrodemos O, Rangan B, Garcia S, Sandoval Y, Burke MN, Brilakis E
10.4244/EIJ-D-22-00599
free
Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial
Montone R, Cosentino N, Graziani F, Gorla R, Del Buono M, La Vecchia G, Rinaldi R, Marenzi G, Bartorelli AL, De Marco F, Testa L, Bedogni F, Trani C, Liuzzo G, Niccoli G, Crea F
10.4244/EIJ-D-22-00178
free

Peripheral interventions

Paclitaxel-coated balloons for femoropopliteal peripheral arterial disease: final five-year results of the IN.PACT Global Study
Zeller T, Brodmann M, Ansel G, Scheinert D, Choi D, Tepe G, Menk J, Micari A
10.4244/EIJ-D-21-01098
free

Editorial comment

Drug-coated balloons in the real world: do they hold up?
Secemsky E, Korjian S
10.4244/EIJ-E-22-00046
free

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved